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Using Artificial Intelligence and Web Media Data
to Evaluate the Growth Potential of Companies
in Emerging Industry Sectors
Andrew Droll, Shahzad Khan, Ehsanullah Ekhlas, and Stoyan Tanev
Introduction
Efficient, intelligent tools to evaluate the growth and 
competitive potential of new technology startups and 
existing firms in a newly emerging industry sector 
would deliver valuable insight to stakeholders in many 
spheres: companies, entrepreneurs, governments at all 
levels, and investors. However, attempts to study such 
firms are typically hindered by a lack of sufficient in-
formation about the new business sector and the reluct-
ance of the firms – especially startups – to openly share 
detailed information about their specific business inten-
tions and their actual or potential competitive moves. 
In this article, we focus on a sector that typifies these 
challenges: the emerging precision medicine sector of 
the healthcare industry. Precision medicine is a new 
medical approach that promotes the customization of 
healthcare with medical decisions, practices, and 
products that are tailored to specific patient groups or 
individual patients sharing the same treatment needs 
(Vicini et al., 2016). The tools employed in precision 
medicine include molecular diagnostics, imaging, and 
analytics that are used to select appropriate and optim-
al therapies based on the context of a patient’s genetic 
makeup or the results of other molecular or cellular 
analyses. The establishment of the precision medicine 
sector has enabled the emergence of new startups fo-
cusing on the development of such types of tools as 
well as the engagement of incumbent medical compan-
ies in the exploration of similar business opportunities. 
The case of technology startups in this business area is 
of particular interest. They are expected to win large 
business deals by competing to create value in the pre-
cision medicine value chain through the development 
of platforms that could be used to interpret and analyze 
data, thereby contributing to better diagnoses. 
In this article, we describe our efforts to adapt and validate a web search and analytics tool 
– the Gnowit Cognitive Insight Engine – to evaluate the growth and competitive potential of 
new technology startups and existing firms in the newly emerging precision medicine sec-
tor. The results are based on two different search ontologies and two different samples of 
firms. The first sample includes established drug companies operating in the precision 
medicine field and was used to estimate the relationship between the firms’ innovativeness 
and the extent of online discussions focusing on their potential growth. The second sample 
includes new technology firms in the same sector. The firms in the second sample were 
used as test cases to determine whether their growth-related web search scores would re-
late to the degree of their innovativeness. The second part of the study applied the same 
methodology to the real-time monitoring of the firms’ competitive actions. In our findings, 
we see that our methodology reveals a moderate degree of correlation between the Insight 
Engine’s algorithmically computed relevance scores and independent measures of innova-
tion potential. The existence of such correlations invites future work in attempting to ana-
lyze company growth potential using techniques founded in web content scraping, natural 
language processing, and machine learning.
The world needs a better understanding of how 
to encourage innovation. And innovators need 
to get better at it. Sign me up.
Robert Metcalfe
Co-Inventor of Ethernet and Founder of 3Com
“ ”
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However, it is very difficult to study such firms due to 
the insufficiency of information and their own discre-
tion about their specific competitive differentiation 
strategies. The present article suggests a research ap-
proach that could deal with such information insuffi-
ciency and discretion by using keyword-based web 
search techniques and public information that was 
made available online by third parties. This approach 
represents an original attempt to study companies’ po-
tential for innovation by tuning a developing, innovat-
ive competitive intelligence platform for the task of 
evaluating media perceptions of competitive advantage 
and growth potential in the precision medicine space.
The article is structured as follows. First, we further de-
scribe precision medicine, including both the scope of 
opportunities in the sector and the challenges of study-
ing the potential growth of companies within it. Then, 
we describe our research design and the Gnowit Cognit-
ive Insight Engine, which we used for the analyses of 
the firms’ growth potential, innovativeness, and com-
petitive actions. After presenting and discussing the res-
ults of these analyses, we offer conclusions and identify 
future areas of research.
Background: The Precision Medicine Sector
The sphere of precision medicine represents a dramatic 
departure from prior perspectives on innovation in 
healthcare. Whereas prior medical treatments have 
widely been based on targeting an “‘average patient’” 
in the general population, precision medicine describes 
an approach in which individuals’ measurable unique 
characteristics across a multitude of genetic, medical, 
and lifestyle-related parameters define how treatments 
should be administered (White House, 2015). Instead of 
rigid prescribed treatment regimes, precision medicine 
offers highly customizable treatment programmes 
tailored to provide much more efficient individualized 
care (Wikipedia, 2017). In 2015, to support innovation 
in precision medicine, the United States government 
launched the Precision Medicine Initiative and the affil-
iated All of Us Research Program (allofus.nih.gov). The All 
of Us program aims to aggregate data from a popula-
tion of one million volunteers, including data on gen-
omes, microbiomes, and epigenomes. The data 
collected by All of Us will be federated in a large data-
base accessible to researchers for scientific purposes.
It is expected that broad effects on healthcare will mani-
fest from developments in precision medicine. Better 
understanding and use of individual genetic signals, 
more customizable medical devices, and personalized 
diagnoses based on deep analyses of patient data rep-
resent some of the foremost aspirations with regard to 
potential for advancement in this field. As the field de-
velops, new business models will emerge from compan-
ies of all sizes in their efforts to bring products to 
market. These models will be enabled by technological 
advancement and innovation in spheres including mo-
lecular diagnostics, medical imaging, and big data ana-
lytics (Knowledge@Wharton & SAP, 2016).
Business researchers and practitioners are increasingly 
focusing on studying the potential growth of specific 
companies in the precision medicine sector as well as 
the innovation strategies that could make a difference 
in terms of potential patient health outcomes. For ex-
ample, a recent study provided ranked 23 biopharma-
ceutical companies based on the extent to which they 
are driving innovation in precision medicine (Amplion, 
2016). The ranking is based on: i) how many precision 
medicine products a company currently markets; ii) the 
percentages of the company’s recent clinical trials that 
involve biomarkers; iii) the number of novel oncology 
drugs the company has in its pipeline; and iv) the num-
ber of proprietary biomarkers the company is using in 
its clinical trials. 
Another recent study listed a number of technology 
companies that are likely to be leaders in precision 
medicine for years to come (Borukhovich, 2016). Their 
selection was based on their innovation potential due 
to their listing in the Crunchbase company database 
(www.crunchbase.com). The companies are not ranked in 
any way because they are at a relatively early stage of 
their lifecycles. The list of companies allows the analys-
is of emerging value propositions in the precision medi-
cine technology sector. However, the early stage of the 
companies suggests that many of them are in a stealth 
mode that does not allow them to share the details of 
their specific competitive strategies and the analysis of 
their growth potential. Thus, business analysts, re-
searchers, and potential investors are left to their own 
means and to information that is available online in ex-
amining the growth, innovation, and investment poten-
tial of such early-stage firms. The situation highlights 
the increasing need to develop appropriate competitive 
intelligence tools and techniques that could use pub-
licly available online information about newly emer-
ging firms to evaluate their growth potential and 
competitiveness. 
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Research Methodology 
The methodology used in the research for this article 
was structured around using keyword-based web 
search and real-time media monitoring techniques to 
analyze publicly available online data about companies 
to be studied. This approach was taken in combination 
with the use of the Gnowit Cognitive Insight Engine 
(Gnowit engine, www.gnowit.com), a platform that uses 
machine learning to analyze the magnitude of similar-
ity between corpuses of documents. The Gnowit engine 
was principally developed by Andrew D. Droll, Lead 
Data Scientist at Gnowit Inc., by building on the expert-
ise of Shahzad Khan, CTO of Gnowit Inc.; together, they 
are the first two co-authors of this article. The research 
methodology was shaped in collaboration between 
Gnowit and the two other co-authors who are research-
ers at the University of Southern Denmark. There are at 
least two substantial prospective advantages associated 
with focusing on information that is provided online by 
third parties. First, in many cases, this is the only valu-
able information that is available about early-stage 
companies. Second, information provided by third 
parties is expected to be un-biased with respect to the 
scarce marketing information provided by the compan-
ies themselves. With this research, we aimed to determ-
ine whether this type of data, when combined with a 
machine learning approach, could produce useful in-
sight into companies’ growth potential.
We started our study by examining the relationship 
between the intensity of online media discussions fo-
cusing on the business growth of companies in the 
pharmaceutical and biotechnology industries, and the 
empirical ranking of their innovativeness such as 
provided by independent third-party sources. To this 
end, the Gnowit engine was employed to analyze textu-
al data collected from online publications that are avail-
able throughout the Internet. Gnowit’s crawler 
architecture automatically collects news article content 
from more than 8,000 publications, including the 
largest newspapers in the world, and extending down 
to a number of small regional and local papers and out-
lets. All of this data was available to the Gnowit engine 
during our experimentation.
To analyze this aggregated data using the Gnowit en-
gine, we have developed a Boolean query designed to 
extract articles relating to industry growth in the preci-
sion medicine sector. The specific keywords were selec-
ted through a close examination of recent books such 
as Get Backed (Baehr & Loomis, 2015), The Lean Startup 
(Erik Ries, 2011), and Business Model Generation (Oster-
walder & Pigneur, 2010). The final query combined a 
variety of composite keywords focusing on: 
Market growth (“Market size” OR “market 
growth” OR ((fast OR growing) AND market) OR 
“market conditions” OR “attractive market posi-
tion” OR “unique market position” OR “emerging 
market” OR “niche market” OR “new market” OR 
“market confusion” OR “market ambiguity” OR 
“market share” OR “market leader”);
Business growth (“Growth potential” OR “busi-
ness growth” OR “growing momentum” OR 
“growth strategy” OR “fast-growing company” OR 
“growing sales” OR “sales growth” OR “revenue 
growth” OR “ramp up sales” OR “growing market 
demand” OR “growing customer demand” OR 
“scale up” OR “boosting revenue” OR “increasing 
revenue” OR “greater product sales” OR “new ser-
vice income” OR “minimize costs” OR “new reven-
ue streams” OR “sustainable revenue” OR 
“stimulate growth” OR “growth indicators” OR 
“growth factors” OR “competitor growth strategy” 
OR “competitive strengths” OR “business 
strengths” OR “increasing return” OR “increasing 
income”);
Competitive differentiation strategy (“Business 
differentiation” OR “competitive differentiation” 
OR “market differentiation” OR “competitive ad-
vantage” OR “business advantage” OR “unique 
value proposition” OR “unique selling point” OR 
USP OR “competitive position”).
The three composite keywords above were connected 
through a logical OR operator. The resulting larger com-
posite keyword was connected through a logical AND 
with the terms “precision medicine” and “personalized 
medicine”. The final result was a query, or “search onto-
logy”, which we labelled Precision Medicine Growth 
(PMG). The Gnowit engine is usually used to compare 
companies on the basis of their relationship to certain 
specific single signals; however, Gnowit’s systems per-
mit comparisons across several signals at once, mean-
ing it can classify a company’s media coverage in a true 
ontological fashion. This query served as a heuristic to 
isolate a set from several document sources that were 
initially pre-collected and maintained by Gnowit: Cana-
dian Online News, Government – Med Sources, Tech 
Startup News – USA, and US Online News. 
The Gnowit engine used the PMG query as an instruc-
tion to perform the following steps: 
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1. Retrieve the collection of the latest published articles 
that match the query heuristic. 
2. Tokenize the content of these articles in a way that 
leads to the construction of a set of textual terms and 
numeric weightings for each term. This step trans-
forms each document into a term-weighting vector.
3. Add the individual document term-weighting vectors 
together to create an aggregate term-weighting vec-
tor for the entire PMG heuristic (henceforth called 
the “PMG vector”).
4. Store this aggregated heuristic vector as a retrievable 
context vector that can be used to provide numeric 
strength-of-similarity analysis with other similar 
heuristically-developed aggregate vectors. 
The capability described above was leveraged as fol-
lows. We used as a case study the sample of 23 compan-
ies that were ranked by (Amplion, 2016) in terms of 
their innovativeness in precision medicine. For each of 
these companies, we developed an additional individu-
al Boolean query designed to act as a heuristic return-
ing articles that relate to that company name alone. 
Subsequently, we submit an instruction to the GCIE 
that requests the computation of an aggregate heuristic 
vector (in the same way as described above for generat-
ing the PMG vector) for each company name heuristic, 
and returns back a numeric value corresponding to its 
strength-of-correspondence to the initially calculated 
PMG vector. As a result, each company now has a nu-
merical strength-of-correspondence measure that 
could be used to evaluate its potential growth in the 
precision medicine sector. We refer to this measure as 
the PMG Gnowit score. 
In the second part of our work, we applied the above 
methodology to another research context – real-time 
monitoring of the competitive actions of the same com-
panies. This specific choice of the second research con-
text was motivated by the insights from a closer 
examination of the way Gnowit search engine operates. 
The Gnowit engine does not search across all articles 
on the Internet; rather, it only searches across those art-
icles that were published in a period starting two weeks 
in the past and ending at the present moment– a limita-
tion imposed by the company’s infrastructure cost con-
straints as a small startup. The time period for the 
search is a moving time window that looks only two 
weeks back in time. In this sense, it might be best suited 
for the monitoring of most recent events or actions cor-
responding to firms’ current competitive strategy. That 
is why we constructed a new search ontology focusing 
on competitive actions. The construction of the new on-
tology was done on the basis of insights from McInnis 
(2008) and Grimm and colleagues (2006). The query cor-
responding to competitive actions in precision medi-
cine (CAPM) took the following form:
((“Asset development” OR “Resource adjustment”) 
OR (“Brand awareness” OR “Brand loyalty”) OR 
(“Intellectual property” OR “Product Develop-
ment” OR “Product improvement” OR “Product 
design”) OR (“Competitive strategy” OR “Competit-
ive advantage” OR “Competitive market position” 
OR “strong market position” OR “Time to market” 
OR “lower entry barriers” OR “Joint ventures” OR 
“Economies of scale” OR “economy of scale”) OR 
(“accelerate adoption” OR “market adoption” OR 
“viable business model” OR “solid business mod-
el” OR “category leader” OR “customer engage-
ment “ OR “customer involvement” OR “User 
driven”) OR (“Demonstrate performance” OR “De-
velopment center” OR “Exceed goals” OR “Expand 
adoption” OR “Deliver more value”) OR (Funding 
OR “Global expansion” OR “Global reach” OR 
Grow OR growth OR “product availability” OR 
“Strength management” OR “technology support”) 
OR (Innovation OR “innovation at a fraction of the 
cost” OR “cost effective innovation” OR “innova-
tion at lower cost” OR “Product innovation”) OR 
(“join executive” OR “join leaders” OR “joint solu-
tion”) OR (“launch product” OR “launch solution” 
OR “lead emerging technology” OR “lock-in” OR 
“lower cost ownership”) OR (“new alternative” OR 
partner OR “partner program” OR “partner trusted 
provider” OR “powerful capabilities” OR “rapid de-
velopment” OR “rapid innovation” OR “reduce 
costs” OR “regional expansion”)) AND (“precision 
medicine” OR “personalized medicine”) 
The replication of the search methodology on the basis 
of the CAPM ontology resulted in a CAPM vector that 
was used to measure the competitive activity of PM 
firms. We refer to this measure as the CAPM Gnowit 
score.
Research Findings
The methodology described in the previous section al-
lowed us to evaluate the correlation between Amplion’s 
innovation ranking and the PMG Gnowit score, which 
corresponds to the intensity of online media discussions 
of companies’ focus growth in the precision medicine 
sector. 
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Ranking firms by PMG Gnowit scores
Table 1 lists the 23 companies that were ranked by 
Amplion (2016) in terms of their innovativeness in the 
precision medicine field. The table also includes their 
innovation ranking and two sets of PMG Gnowit scores 
corresponding to their growth potential in the precision 
medicine sector. The results in Table 1 compare the 
firms’ innovation ranking and the PMG Gnowit scores 
for two different two-week time periods: December 13 
to 17, 2016,and January 20 to February 3, 2017, 2017. 
Figure 1 illustrates the PMG Gnowit scores for all 23 
firms in the second time period. The numerical differ-
ence in scores between these periods is due to shifting 
coverage of these companies and of the precision medi-
cine space over time. Variance of this type is normal be-
cause it is based on current news coverage. The main 
element of interest is that of scores relative to each oth-
er across different companies (though this will also shift 
as news coverage changes, for example in response to 
product announcements or releases or company finan-
cial announcements).
Figure 1 shows that the highest scores in the second 
period belong to Johnson & Johnson, followed by Mer-
ck, Pfizer, Bristol-Myers Squibb, and Roche. Table 1 
also reveals substantial differences in the scores 
between successive time periods depending on the de-
gree of online discussions associated with a particular 
firm. For example, there was a 10-times increase in 
Roche’s PMG Gnowit score in the second time period. 
Such radical changes could be explained by the nature 
of the Gnowit search engine, which focuses on monitor-
ing online discussions that happened in the last 
twoweek period. It could happen then, for example in a 
time of reporting impressive (or disappointing) quarter 
results, that the name of a specific company has been 
involved in an unusually high number of online discus-
sions in the past two weeks, leading to an unusually 
high PMG Gnowit score. 
The above discussion leads to three important points: 
1. The suitability of the Gnowit engine for a specific 
search will depend on the context of the research pro-
ject. In our present case, we are trying to evaluate the 
growth potential of firms in an emerging industry 
sector. It is clear that the evaluation of such potential 
should not be based on online information collected 
over just two weeks. The evaluation of the growth po-
tential should extend the methodology by including 
the possibility to accumulate or integrate multiple 
successive two-weeks results over a longer period of 
time, such as six months, a year, or longer. 
2. The evaluation of the growth potential cannot be 
based on the quantitative results alone and should in-
corporate additional qualitative semantic textual ana-
lysis. The Gnowit search platform offers additional 
analytical capabilities that allow for sentiment ana-
lysis to indicate the degree to which the online dis-
cussions are associated with positive or negative 
statements. This feature was not included in the 
present study and will become the subject of future 
studies. 
3. The two-week search window feature of the Gnowit 
search engine suggests that it could be more directly 
applicable to the real-time monitoring of firms’ com-
petitive actions because such actions might have a 
real-time competitive effect on competitors. 
Figure 1. Ranking of the 23 innovative drug companies in terms of their PMG Gnowit scores. The graph was 
automatically generated by the Gnowit search platform.
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Table 1. Innovation ranking of 23 established firms in the emerging precision medicine sector (Amplion, 2016) 
together with their PMG Gnowit scores corresponding to the intensity of online discussions about their growth 
potential in the PM sector
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Relationship between innovativeness and PMG Gnowit 
score
For the first measurement period, the Spearman correla-
tion coefficient between the innovation ranking and the 
PMG Gnowit score was 0.38 (p < 0.1). In the second peri-
od, it was 0.43 (p < 0.05). Even though the statistically 
significant correlation coefficients correspond to a mod-
erate degree of correlation, their degree of statistical sig-
nificance may vary across different time periods 
depending on the intensity of online discussions in a 
specific time period. Nevertheless, a moderate or high 
statistically significant degree of correlation suggests 
the existence of a relationship between a firm’s PMG 
Gnowit score and its innovativeness. Such relationship 
will obviously depend on the specific terminological 
composition of the search ontology. We can claim, 
however, that our growth potential search ontology 
seems to have worked well in detecting a relationship 
between growth terminology and innovativeness. The 
existence of such relationship suggests that the method-
ology based on our growth potential search ontology 
could be applied to study the growth and innovation po-
tential of earlystage companies for which there is no 
competitive intelligence information. To test this as-
sumption, we will apply the methodology to the preci-
sion medicine technology companies that were 
identified as promising by Borukhovich (2016). 
Applying the methodology to studying the innovativeness 
of new precision medicine technology firms 
In this section, we present results of the PMG Gnowit 
score ranking of a sample of 29 new technology-based 
firms in the precision medicine sector (Borukhovich, 
2016). Table 2 shows the results for the PMG Gnowit 
scores of these firms in the second time period. Only 6 
firms had a nonzero score (Table and Figure 2). The rest 
of the firms did not have any online coverage in this par-
ticular period. 
The previous results about the correlation between 
firms’ innovativeness and their PMG Gnowit scores, to-
gether with the results shown in Table 2, were expected 
to provide us with a basis to estimate the degree of in-
novativeness of the firms shown in Figure 2. In addition, 
the results shown in Table 2 would suggest that there 
was no innovative activity by most of the firms. Such 
conclusions, however, should be subjected to the same 
considerations as the ones made in the previous sec-
tions. First, the results as such do not allow such conclu-
sions unless we have performed online measurements 
across multiple successive two-week periods, which 
would allow us to estimate the aggregated effect of the 
online discussions over a longer period of time. Second, 
Table 2. PMG Gnowit scores of 29 innovative new 
technology firms in the precision medicine sector
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the functionality of the Gnowit search engine could be 
better suited to search ontologies focusing on monitor-
ing real-time competitive moves of firms in an emer-
ging industry sector. 
Applying the methodology to studying the competitive 
actions of precision medicine firms
In this section, we apply the competitive action search 
ontology to study the real-time competitive actions of 
the same two samples of firms that were studied in the 
previous sections. Table 3 shows the list of the firms to-
gether with their innovation ranking (the same as Table 
1) and their CAPM Gnowit scores. Figure 3 provides 
ranks the firms in terms of their CAPM Gnowit scores 
(measuring coverage related to competitive advantage 
in the precision medicine space). The correlation coeffi-
cient between firms’ innovativeness and their CAPM 
Gnowit scores is 0.439 (p < 0.05), which suggests again a 
moderate degree of correlation. 
The visible degree of correlation between the firms’ de-
gree of innovativeness and their CAPM Gnowit score 
again offers the opportunity to use the competitive ac-
tion ontology to estimate the innovation potential of 
the 29 new technology firms in the precision medicine 
sector (Borukhovich, 2016). 
Table 4 lists 5 out of the 29 firms that had some online 
coverage in the second time period; the rest of the firms 
did not have such coverage. Figure 4 shows the five 
firms in terms of their CAPM Gnowit scores. The results 
show that Cellular Dynamics Int (CDI) has the highest 
CAPM Gnowit score. Table 5 provides details of three 
documents referring to CDI that were found to be most 
relevant in the search. The relevance of a particular on-
line document within the context of the specific search 
project is defined by a relevance score calculated by the 
Gnowit search platform on the basis of the semantic 
correlation of the content of the document and the 
Figure 2. Ranking of the six new technology firms with growth-oriented online coverage in the second time period
Figure 3. CAPM Gnowit score ranking of the 23 drug firms operating in the precision medicine sector over the second 
time period
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Table 3. CAPM Gnowit scores of the 23 drug firms over the second time period
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Figure 4. CAPM Gnowit score ranking of five new technology firms operating in precision medicine sector
Table 4. CAPM Gnowit scores of five innovative new technology firms in the precision medicine sector that had 
online coverage focusing on competitive actions
Table 5. List of the online documents about Cellular Dynamics Int (CDI) with the highest relevance for the search 
focusing on competitive actions
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search ontology. The specifics of the semantic correla-
tion are out of the scope of this article; however, for a 
high-level view, the scores are derived in the following 
way. First, Gnowit’s search engine is queried for the art-
icles matching the search ontology terms. These articles 
are analyzed using natural language processing tech-
niques to extract a characteristic linguistic profile for 
the associated query in recent media coverage. Then, 
when plots are generated, the same process is per-
formed for companies themselves. Articles relating to 
each company are retrieved from Gnowit’s search en-
gine via query, and these are analyzed to produce a 
characteristic linguistic profile for the companies. Fi-
nally, a similarity measure is applied to generate lin-
guistic proximity scores between media coverage 
relating to the search ontology terms and the compan-
ies undergoing analysis. By comparing these scores 
across companies using the same underlying search on-
tology terms, we obtain relative measures of company 
discussion in the media.
The information provided in Table 5 offers just a glance 
of how the Gnowit search engine could be used to mon-
itor the competitive actions of new firms in an emer-
ging industry sectors. The validation and automation of 
such search projects needs more systematic research 
studies, which will be the subject of future efforts. 
Conclusion
This article presented the results of a research study fo-
cusing on adapting and validating the use of a business 
intelligence tool – the Gnowit Cognitive Insight Engine 
– for entrepreneurship and innovation research. The fo-
cus of the study was on uncovering the exploratory and 
analytics potential of the existing functionality of the 
Gnowit search engine and the ultimate objective is to ar-
ticulate insights that could further enhance its potential 
as a competitive intelligence tool for entrepreneurs, in-
vestors, managers, and entrepreneurship scholars. The 
results provide a first glance at this potential and high-
light opportunities for future studies in this direction.
In particular, we hope in the future to be able to expand 
the time interval for news coverage to be analyzed bey-
ond Gnowit’s current two-week scope. A longer time 
period will allow more comprehensive and significant 
evaluations of the significance of the types of measures 
that we examine in this article. Also, this avenue could 
open the possibility of developing an engine to monitor 
changes in companies’ potential over time, potentially 
kept up-to-date in real time, which could provide true 
utility to researchers and companies in the wild. As the 
current time restriction is primarily one borne of re-
source constraints, investments in Gnowit’s technology 
may permit this type of exploration in the future. Fi-
nally, additional research opportunities are presented 
by the capabilities of Gnowit’s technology not yet ex-
plored by this article. In particular, in this article, we 
only examined comparisons between companies using 
search ontologies consisting of a single search term – in 
effect, doing one-dimensional analyses of the compan-
ies’ relative media impressions. The Gnowit ontology 
engine supports ontologies with dozens of terms, which 
might permit the generation of significant, multi-dimen-
sional comparisons and analyses of companies’ impres-
sions in the media across many signals of interest.
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